02 Apr 2026 SwiftPharma Expands R&D Footprint to Leuven in Strategic Co-Location with Benno Therapeutics Multiple categories
19 Feb 2026 SwiftPharma announces partnership with Medicines Patent Pool and Population Council on Project ELYRA to expand pathways for Griffithsin-based STI prevention Multiple categories
20 Nov 2025 Gevers strengthens its leadership position with the acquisition of patent firm Pecher & Partners Member news
19 Nov 2025 P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
15 Sep 2025 Mdxhealth announces closing of Exosome Diagnostics acquisition from Bio-Techne Multiple categories
10 Sep 2025 GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions Multiple categories
25 Aug 2025 argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
